NIKI · Niki BioSolutions, Inc.

Summary

Aptorum Group Limited received a Nasdaq notification dated March 5, 2026, for non-compliance with the minimum bid price requirement of $1 per share under Nasdaq Listing Rule 5550(a)(2). The company has a 180-calendar-day grace period until September 1, 2026, to regain compliance and intends to evaluate options including a reverse stock split.

Key takeaways

• Notification received March 5, 2026, for minimum bid price deficiency
• Non-compliance with Nasdaq Listing Rule 5550(a)(2) requiring $1 per share
• 180-calendar-day grace period until September 1, 2026
• Listing and trading not immediately affected
• Plans to evaluate options including reverse stock split
• Committed to maintaining Nasdaq listing